PAXIL CR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp. The primary component is Paroxetine Hydrochloride Hemihydrate.
Product ID | 60505-4378_10f7d0ca-3710-c45c-eb05-8de85aa51b95 |
NDC | 60505-4378 |
Product Type | Human Prescription Drug |
Proprietary Name | PAXIL CR |
Generic Name | Paroxetine Hydrochloride |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2011-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020936 |
Labeler Name | Apotex Corp |
Substance Name | PAROXETINE HYDROCHLORIDE HEMIHYDRATE |
Active Ingredient Strength | 25 mg/1 |
Pharm Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2011-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020936 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-01-01 |
Ingredient | Strength |
---|---|
PAROXETINE HYDROCHLORIDE HEMIHYDRATE | 25 mg/1 |
SPL SET ID: | 483bd97f-c4d0-4e23-aaa8-6334f4471e0c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
71335-0572 | PAXIL CR | PAXIL CR |
60505-3669 | PAXIL CR | PAXIL CR |
60505-3670 | PAXIL CR | PAXIL CR |
60505-3668 | PAXIL CR | PAXIL CR |
60505-4378 | PAXIL CR | PAXIL CR |
60505-4377 | PAXIL CR | PAXIL CR |
60505-4379 | PAXIL CR | PAXIL CR |
0904-5676 | PAROXETINE | paroxetine hydrochloride |
0904-5677 | PAROXETINE | paroxetine hydrochloride |
0904-5678 | PAROXETINE | paroxetine hydrochloride |
0904-5679 | PAROXETINE | paroxetine hydrochloride |
10544-433 | PAROXETINE | paroxetine hydrochloride |
10544-809 | PAROXETINE | paroxetine hydrochloride |
12634-248 | PAROXETINE | paroxetine hydrochloride |
16714-181 | Paroxetine | Paroxetine Hydrochloride |
16714-182 | Paroxetine | Paroxetine Hydrochloride |
16714-183 | Paroxetine | Paroxetine Hydrochloride |
16714-184 | Paroxetine | Paroxetine Hydrochloride |
21695-101 | Paroxetine | Paroxetine Hydrochloride |
21695-102 | Paroxetine | Paroxetine Hydrochloride |
21695-103 | Paroxetine | Paroxetine Hydrochloride |
21695-104 | Paroxetine | Paroxetine Hydrochloride |
43353-845 | Paroxetine | Paroxetine Hydrochloride |
0378-2003 | Paroxetine Hydrochloride | paroxetine hydrochloride |
0378-2004 | Paroxetine Hydrochloride | paroxetine hydrochloride |
0378-2005 | Paroxetine Hydrochloride | paroxetine hydrochloride |
21695-159 | PAXIL | paroxetine hydrochloride |
21695-160 | PAXIL | paroxetine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PAXIL 75284309 2220043 Live/Registered |
GLAXOSMITHKLINE LLC 1997-04-30 |
PAXIL 75282874 2220037 Live/Registered |
GLAXOSMITHKLINE LLC 1997-04-30 |
PAXIL 75180864 not registered Dead/Abandoned |
SmithKline Beecham Corporation 1996-10-15 |
PAXIL 75180863 not registered Dead/Abandoned |
SmithKline Beecham Corporation 1996-10-15 |
PAXIL 75169719 2219909 Live/Registered |
GLAXOSMITHKLINE LLC 1996-09-20 |
PAXIL 75169698 2166898 Dead/Cancelled |
SmithKline Beecham Corporation 1996-09-20 |
PAXIL 75169697 2219908 Live/Registered |
GLAXOSMITHKLINE LLC 1996-09-20 |
PAXIL 75169675 2144154 Live/Registered |
GLAXOSMITHKLINE LLC 1996-09-20 |
PAXIL 74184442 1821952 Live/Registered |
GLAXOSMITHKLINE LLC 1991-07-12 |
PAXIL 73255881 1170889 Dead/Cancelled |
Boehringer Ingelheim G.m.b.H. 1980-03-28 |